Cargando…
Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignancy. Existing therapeutic strategies only provide a small survival benefit in patients with PDAC. Laboratory and clinical research have identified various populations of stem-cell-like cancer cells or cancer stem c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571629/ https://www.ncbi.nlm.nih.gov/pubmed/31108941 http://dx.doi.org/10.3390/jcm8050702 |